期刊文献+

肿瘤免疫逃逸机制的研究进展 被引量:44

Research progress on the mechanism of tumor immune escape
下载PDF
导出
摘要 机体中偶然出现的肿瘤细胞可被免疫细胞所识别,并作为异物而加以清除,但肿瘤在机体的免疫监视下仍能产生、发展和转移,表明肿瘤具有免疫逃逸的能力。本文综述了肿瘤免疫过程中肿瘤抗原表达、识别、加工、递呈、T细胞增殖、活化和分化以及免疫效应的产生等一系列环节中肿瘤免疫逃逸机制的研究进展。 Tumor cells generated occasionally in the body can be identified and removed as a foreign body by immune cells.The generation,development and metastasis of tumor cells although under the body′s immune surveillance,suggest that the tumor cells have the capability of immune escape.In this paper,the research progress of tumor immune escape in the process of tumor immunity including tumor antigen expression,identification,processing,presenting,T cell proliferation,activation and differentiation,as well as the emergence of immune effect is reviewed.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2013年第5期619-624,共6页 Fudan University Journal of Medical Sciences
基金 国家“重大新药创制”科技重大专项“微生物药物技术创新与新药创制产学研联盟”(2010ZX09401-403)~~
关键词 肿瘤细胞 树突状细胞 免疫抑制因子 免疫逃逸 tumor cells dendritic cells immunosuppressive factor immune escape
  • 相关文献

参考文献32

  • 1(美)R.A.Weinberg著.癌生物学[M].詹启敏,刘芝华,泽.北京:科学出版社.2009:641.
  • 2张晶,谢幸,叶大风.黏附分子与肿瘤免疫逃逸[J].实用肿瘤杂志,2004,19(5):449-452. 被引量:18
  • 3Bai XF,Liu J,Li O,et al. Antigenic drift as a mechanism for tumor evasion of destruction by eytolytic T lymphocytes[J]. J Clin Invest, 2003, 111 (101:1487 - 1496.
  • 4Diepstra A, Poppema S, Boot M, et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin s lymphoma[J]. Tissue Antigens,2(1(18, 71(3) 219 - 226.
  • 5Vander VA, Dougherty JT. Starnbach MN. Down- modulation of TCR expression by Salmonella enterica serovar Typhinmrium[J]. J Immunol, 2008, 18(}: 5569 - 5574.
  • 6Yan WH. Human leukocyte antigen G in cancer:Are they clinically relevant? [J]. Cancer Lett,2(111,311(21:123 - 130.
  • 7Wiendl H, Mitsdoerffer M, Hofmerister V, et ag. A functional role of HLA-G expression in human gliom as: an alternative strategy of immune escape[J]. J Immunol, 2002,168(9) :4772 - 4780.
  • 8Chang CC,Campoli M, Ferrone S. HLA class I antigen expression in malignant cells: why dose it not always correlate with CT L mediated lysis[J] Curt Opin Immuno1,2004,16(5) :644 - 650.
  • 9He X,Dong DD, Yie SM, et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro [J]. Ann Surg Oncol, 2010,17(51:1459 - 1469.
  • 10Schwartz RH. Costimulation of T lymphocytes:the role of CD28, CTLA-4, and B7/ BB] in interleukin2 production and immunotherapy[J]. Cell, 1992,71 : 1 065.

二级参考文献15

  • 1O'CONNELL J, BENNETT MW, O'SULLIVAN GC, et al. The Fas counterattack: cancer as a site of immune privilege [J]. Immunol Today, 1999, 20(1) :46-52.
  • 2SCHIMONISHI T, ISSE K, SHIBATA F, et al. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of introhepatic cholangiocareinoma reflect evasion from immune surveillance [J].Hepatology, 2000, 32(4) : 761-762.
  • 3CHANG MY, CHONG IW, CHEN FM, et al. High frequency of frameshift mutation on p53 gene in Taiwan Residents with non small cell lung cancer [J]. Cancer Lett, 2005, 222(2):195-204.
  • 4SCHEIDER-STOCK R, MAWRIN C, MOTSCH C, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer[J]. Am J Pathol, 2004, 164(4) :1233-1241.
  • 5KOCH M, BECKHOVE P, DEN WINKEL JO, et al. Tumor infiltrating T lymphocytes in colorectal cancer : Tumor-selective activation and cytotoxic activity in situ [J]. Ann Surg, 2006, 244(6) :986-992.
  • 6ZHANG J, XU G. Suppression of FasL expression in tumor ceils and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells [J].Cancer Genet Cytogenet, 2007, 179(2):112-117.
  • 7PRETSCHER D, DISTEL LV, GRABENBAUER GG, et al. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma[J].BMC Cancer, 2009, 22(9) :292.
  • 8ENAMI A, TSUTSUMI K, KOBAUASHI T, et al. Correlation between Fas/Fas-ligand expression and apoptosis in undifferentiated nasopharyngeal carcinoma [J].Nippon Jibiinkoka Gakkai Kaiho, 2002, 105(10) :1087-1092.
  • 9O'CONNELL J, BENNETT MW, O'SULLIVAN GC, et al. The Fas counterattack: a molecular mechanism of tumor immune privilege [J]. MotMed, 1997, 3(5)294-300.
  • 10DEVERAUX PL, TAKAHASHI R, SALVESEN GS, et al. X- linked IAP is a direct inhibitor of cell-death proteases [J]. Nature,1997, 388 (17):300-304.

共引文献31

同被引文献624

引证文献44

二级引证文献306

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部